Sort by
Items per page

Send to

Choose Destination

Best matches for Överby AK[au]:

Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Ruzek D et al. Antiviral Res. (2019)

The Role of Viperin in Antiflavivirus Responses. Lindqvist R et al. DNA Cell Biol. (2018)

Tick-Borne Flaviviruses and the Type I Interferon Response. Lindqvist R et al. Viruses. (2018)

Search results

Items: 36


Quantitative proteomics of Uukuniemi virus - host cell interactions reveals GBF1 as proviral host factor for phleboviruses.

Uckeley ZM, Moeller R, Kühn LI, Nilsson E, Robens C, Lasswitz L, Lindqvist R, Lenman A, Passos V, Voss Y, Sommerauer C, Kampmann M, Goffinet C, Meissner F, Överby AK, Lozach PY, Gerold G.

Mol Cell Proteomics. 2019 Sep 30. pii: mcp.RA119.001631. doi: 10.1074/mcp.RA119.001631. [Epub ahead of print]


Model System for the Formation of Tick-Borne Encephalitis Virus Replication Compartments without Viral RNA Replication.

Yau WL, Nguyen-Dinh V, Larsson E, Lindqvist R, Överby AK, Lundmark R.

J Virol. 2019 Aug 28;93(18). pii: e00292-19. doi: 10.1128/JVI.00292-19. Print 2019 Sep 15.


Characterizing the cellular attachment receptor for Langat virus.

Rodrigues R, Danskog K, Överby AK, Arnberg N.

PLoS One. 2019 Jun 4;14(6):e0217359. doi: 10.1371/journal.pone.0217359. eCollection 2019.


Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.

Ruzek D, Avšič Županc T, Borde J, Chrdle A, Eyer L, Karganova G, Kholodilov I, Knap N, Kozlovskaya L, Matveev A, Miller AD, Osolodkin DI, Överby AK, Tikunova N, Tkachev S, Zajkowska J.

Antiviral Res. 2019 Apr;164:23-51. doi: 10.1016/j.antiviral.2019.01.014. Epub 2019 Jan 31. Review.


Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia-like cells.

Lund H, Pieber M, Parsa R, Han J, Grommisch D, Ewing E, Kular L, Needhamsen M, Espinosa A, Nilsson E, Överby AK, Butovsky O, Jagodic M, Zhang XM, Harris RA.

Nat Commun. 2018 Nov 19;9(1):4845. doi: 10.1038/s41467-018-07295-7.


Correlation of Severity of Human Tick-Borne Encephalitis Virus Disease and Pathogenicity in Mice.

Kurhade C, Schreier S, Lee YP, Zegenhagen L, Hjertqvist M, Dobler G, Kröger A, Överby AK.

Emerg Infect Dis. 2018 Sep;24(9):1709-1712. doi: 10.3201/eid2409.171825.


The Role of Viperin in Antiflavivirus Responses.

Lindqvist R, Överby AK.

DNA Cell Biol. 2018 Sep;37(9):725-730. doi: 10.1089/dna.2018.4328. Epub 2018 Jul 30. Review.


Tick-Borne Flaviviruses and the Type I Interferon Response.

Lindqvist R, Upadhyay A, Överby AK.

Viruses. 2018 Jun 21;10(7). pii: E340. doi: 10.3390/v10070340. Review.


Erratum for Panayiotou et al., "Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation".

Panayiotou C, Lindqvist R, Kurhade C, Vonderstein K, Pasto J, Edlund K, Upadhyay AS, Överby AK.

J Virol. 2018 May 29;92(12). pii: e00501-18. doi: 10.1128/JVI.00501-18. Print 2018 Jun 15. No abstract available.


Cell-type- and region-specific restriction of neurotropic flavivirus infection by viperin.

Lindqvist R, Kurhade C, Gilthorpe JD, Överby AK.

J Neuroinflammation. 2018 Mar 15;15(1):80. doi: 10.1186/s12974-018-1119-3.


Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.

Panayiotou C, Lindqvist R, Kurhade C, Vonderstein K, Pasto J, Edlund K, Upadhyay AS, Överby AK.

J Virol. 2018 Mar 14;92(7). pii: e02054-17. doi: 10.1128/JVI.02054-17. Print 2018 Apr 1. Erratum in: J Virol. 2018 May 29;92(12):.


The interplay between viperin antiviral activity, lipid droplets and Junín mammarenavirus multiplication.

Peña Cárcamo JR, Morell ML, Vázquez CA, Vatansever S, Upadhyay AS, Överby AK, Cordo SM, García CC.

Virology. 2018 Jan 15;514:216-229. doi: 10.1016/j.virol.2017.10.012. Epub 2017 Dec 1.


Viperin Targets Flavivirus Virulence by Inducing Assembly of Noninfectious Capsid Particles.

Vonderstein K, Nilsson E, Hubel P, Nygård Skalman L, Upadhyay A, Pasto J, Pichlmair A, Lundmark R, Överby AK.

J Virol. 2017 Dec 14;92(1). pii: e01751-17. doi: 10.1128/JVI.01751-17. Print 2018 Jan 1.


Cellular requirements for iron-sulfur cluster insertion into the antiviral radical SAM protein viperin.

Upadhyay AS, Stehling O, Panayiotou C, Rösser R, Lill R, Överby AK.

J Biol Chem. 2017 Aug 18;292(33):13879-13889. doi: 10.1074/jbc.M117.780122. Epub 2017 Jun 14.


The role of the poly(A) tract in the replication and virulence of tick-borne encephalitis virus.

Asghar N, Lee YP, Nilsson E, Lindqvist R, Melik W, Kröger A, Överby AK, Johansson M.

Sci Rep. 2016 Dec 16;6:39265. doi: 10.1038/srep39265.


Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects.

Lindqvist R, Mundt F, Gilthorpe JD, Wölfel S, Gekara NO, Kröger A, Överby AK.

J Neuroinflammation. 2016 Oct 24;13(1):277.


Human Tick-Borne Encephalitis and Characterization of Virus from Biting Tick.

Henningsson AJ, Lindqvist R, Norberg P, Lindblom P, Roth A, Forsberg P, Bergström T, Överby AK, Lindgren PE.

Emerg Infect Dis. 2016 Aug;22(8):1485-7. doi: 10.3201/eid2208.151962.


Brain heterogeneity leads to differential innate immune responses and modulates pathogenesis of viral infections.

Zegenhagen L, Kurhade C, Koniszewski N, Överby AK, Kröger A.

Cytokine Growth Factor Rev. 2016 Aug;30:95-101. doi: 10.1016/j.cytogfr.2016.03.006. Epub 2016 Mar 11. Review.


Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1.

Kurhade C, Zegenhagen L, Weber E, Nair S, Michaelsen-Preusse K, Spanier J, Gekara NO, Kröger A, Överby AK.

J Neuroinflammation. 2016 Jan 27;13:22. doi: 10.1186/s12974-016-0487-9.


High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection.

Islam MK, Baudin M, Eriksson J, Öberg C, Habjan M, Weber F, Överby AK, Ahlm C, Evander M.

J Biomol Screen. 2016 Apr;21(4):354-62. doi: 10.1177/1087057115625184. Epub 2016 Jan 13.


Generation of mutant Uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist.

Rezelj VV, Överby AK, Elliott RM.

J Virol. 2015 May;89(9):4849-56. doi: 10.1128/JVI.03511-14. Epub 2015 Feb 11.


Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local antiviral responses.

Weber E, Finsterbusch K, Lindquist R, Nair S, Lienenklaus S, Gekara NO, Janik D, Weiss S, Kalinke U, Överby AK, Kröger A.

J Virol. 2014 Nov;88(21):12202-12. doi: 10.1128/JVI.01215-14. Epub 2014 Aug 13.


Tick-borne encephalitis virus sequenced directly from questing and blood-feeding ticks reveals quasispecies variance.

Asghar N, Lindblom P, Melik W, Lindqvist R, Haglund M, Forsberg P, Överby AK, Andreassen Å, Lindgren PE, Johansson M.

PLoS One. 2014 Jul 24;9(7):e103264. doi: 10.1371/journal.pone.0103264. eCollection 2014.


Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity.

Upadhyay AS, Vonderstein K, Pichlmair A, Stehling O, Bennett KL, Dobler G, Guo JT, Superti-Furga G, Lill R, Överby AK, Weber F.

Cell Microbiol. 2014 Jun;16(6):834-48. doi: 10.1111/cmi.12241. Epub 2013 Dec 3.


Hiding from intracellular pattern recognition receptors, a passive strategy of flavivirus immune evasion.

Overby AK, Weber F.

Virulence. 2011 May-Jun;2(3):238-40. Epub 2011 May 1.


Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Verbruggen P, Ruf M, Blakqori G, Överby AK, Heidemann M, Eick D, Weber F.

J Biol Chem. 2011 Feb 4;286(5):3681-92. doi: 10.1074/jbc.M110.154799. Epub 2010 Nov 30.


Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles.

Overby AK, Popov VL, Niedrig M, Weber F.

J Virol. 2010 Sep;84(17):8470-83. doi: 10.1128/JVI.00176-10. Epub 2010 Jun 16.


Entry of bunyaviruses into mammalian cells.

Lozach PY, Mancini R, Bitto D, Meier R, Oestereich L, Overby AK, Pettersson RF, Helenius A.

Cell Host Microbe. 2010 Jun 25;7(6):488-99. doi: 10.1016/j.chom.2010.05.007.


Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure.

Storla DG, Kristiansen I, Oftung F, Korsvold GE, Gaupset M, Gran G, Øverby AK, Dyrhol-Riise AM, Bjune GA.

BMC Infect Dis. 2009 May 11;9:60. doi: 10.1186/1471-2334-9-60.


NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.

Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, Superti-Furga G, Unger H, Weber F.

J Virol. 2009 May;83(9):4365-75. doi: 10.1128/JVI.02148-08. Epub 2009 Feb 11.


Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers.

Huiskonen JT, Overby AK, Weber F, Grünewald K.

J Virol. 2009 Apr;83(8):3762-9. doi: 10.1128/JVI.02483-08. Epub 2009 Feb 4.


Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses.

Habjan M, Penski N, Wagner V, Spiegel M, Overby AK, Kochs G, Huiskonen JT, Weber F.

Virology. 2009 Mar 15;385(2):400-8. doi: 10.1016/j.virol.2008.12.011. Epub 2009 Jan 19.


Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus.

Overby AK, Pettersson RF, Grünewald K, Huiskonen JT.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2375-9. doi: 10.1073/pnas.0708738105. Epub 2008 Feb 12.


Supplemental Content

Loading ...
Support Center